- Mr. Johnson is a 60-year-old male recently diagnosed with cardiac arrhythmia.
- He is active for his age but experiences discomfort in his chest.
- He used to work as an ambulance paramedic for many years and has the medical background necessary to manage the condition.
- However, Mr. Johnson requires guidance on how to use mobile technology to monitor his heart rhythm.
- Name: KardiaMobile
- Purpose: Allows to provide medical-grade heart readings, including rhythm and EKG analysis using mobile devices
- Intended audience: Patients that are experiencing any cardio related issues or diagnosed with critical cardiac diseases.
- Mobile device(s) upon which it will operate: Smartphone and tablet devices running latest versions of iOS and Android.
- Where to download or obtain it: Apple App Store or Google Play Store for the application. However, additional equipment must be purchased from the company website (AliveCor, n.d.).
- Interface: The interface is simple to use but looks professional and informative.
- Usability: The application allows to take a medical-grade EKG in 30 seconds. It monitors any abnormalities to heart rhythm.
- The application is FDA approved and can be used without a prescription (Van Slooten, 2018).
- Favorite Thing: Hardware is portable and can be attached to Apple Watch devices.
- Favorite Thing: Maintains heart readings over time allowing to see a pattern. It can also be demonstrated to a physician, which helps to provide better treatment.
- The patient can monitor heart rhythm with an extremely accurate measurement device.
- The application evaluates the relationship between heart readings and activity levels.
- Any inconsistencies and abnormalities are noted, and the patient is alerted to maintain attention and possibly see a doctor.
AliveCor. (n.d.). KardiaMobile. Web.We will write a custom Patient Education Technology: KardiaMobile App specifically for you
for only $14.00 $11,90/page 308 certified writers online Learn More
Van Slooten, T. (2018). AliveCor KardiaMobile heart monitor review 2018. Web.